Screening for Long-Term Cardiac Status During Cancer Treatment

Screening for long-term cardiac status during cancer treatment.

1 about 12 million cancer patients survived in the United States in 2007, two thirds of whom were expected to live at least 5 years after the diagnosis. With increases in survival time, the long-term adverse effects of various cancer treatments have become a subject of concern. Chemotherapeutic agents and radiation can cause several such effects; the cumulative incidence of chronic health condi...

Cancer screening of long-term cancer survivors.

BACKGROUND Although 64% of cancer survivors are expected to live at least 5 years beyond diagnosis, the receipt of cancer screening by this population is unclear. The objective of this study was to assess the relation between a cancer diagnosis and future cancer screening, exploring provider-, patient-, and cancer-specific factors that explain observed relationships. METHODS The Wisconsin Lon...

Long-term cardiac effects of treatment for childhood leukemia.

Late cardiac complications in cancer survivors may develop from subclinical myocardial damage. Biochemical correlates of minimal myocardial changes can be analyzed using a commercially available rapid assay. Biomarkers are considered more sensitive markers of subclinical cardiotoxicity than conventional electrocardiographic and echocardiographic methods. The aim of this study was to determine t...

Current Status of Long-term Care in Taiwan: Transition of Long-term Care Plan From 1.0 to 2.0

I-44: Long-Term Sequelae of Polycystic OvarySyndrome: Gynecological Cancer

Women with polycystic ovary syndrome (PCOS) have been reported to be at increased risk of a number of gynecological neoplasias, including endometrial, breast, and ovarian cancer. The data supporting an increased risk is almost entirely inferential, based primarily on small case series or shared risk factors. One of the difficulties in exploring the association between these cancers and PCOS, is...